A study on the effect of add-on rosiglitazone on the anklebrachial pressure index of patients with type 2 diabetes mellitus in hospital Universiti Sains malaysia
Background Rosiglitazone, an oral hypoglycaemic agent of the thiazolidinedione group is used for Type 2 Diabetes treatment. Research has shown that this medication, being a peroxisome proliferator activator receptor-gamma agonist has effects beyond glycaemic control alone. Apart from improving in...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | 学位論文 |
| 言語: | English |
| 出版事項: |
2007
|
| 主題: | |
| オンライン･アクセス: | http://eprints.usm.my/48443/1/Dr.%20NAZRI%20MUSTAFFA.pdf http://eprints.usm.my/48443/ |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|